top of page

Best Poster Awards 2022: Personalized immunotherapy with encapsulated cell technology

Release Tx

Jan 11, 2022

1 min read

Best Poster Awards 2022 – ESMO conference – Our ECT technology as adjuvant to an au

tologous cancer vaccine.

Recent Posts

Release Therapeutics’ CNS-Targeted Encapsulated Cell Technology Wins 2026 Disruptive Innovation Award from Geneva University Hospitals (23 October 2026)

Release Therapeutics’ CNS-Targeted Encapsulated Cell Technology Wins 2026 Disruptive Innovation Award from Geneva University Hospitals (23 October 2026)

Release Therapeutics Secures Non-Dilutive Innosuisse Funding to Expand its Encapsulated Cell Technology Platform into Sanfilippo Syndrome Type IIIA (22 October 2026)

Release Therapeutics Secures Non-Dilutive Innosuisse Funding to Expand its Encapsulated Cell Technology Platform into Sanfilippo Syndrome Type IIIA (22 October 2026)

MVX-ONCO-1 Awarded the 2026 Pfizer Research Prize in Oncology (5 February 2026)

MVX-ONCO-1 Awarded the 2026 Pfizer Research Prize in Oncology (5 February 2026)

Comments

bottom of page